Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components
- 14 May 1992
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 215 (2-3) , 285-287
- https://doi.org/10.1016/0014-2999(92)90040-b
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brainLife Sciences, 1991
- Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smokeNeuropharmacology, 1990
- Effects of subchronic nicotine administration on central dopaminergic mechanisms in the ratNeurochemical Research, 1989
- Ascorbic acid and striatal transport of [3H]1-methyl-4-phenylpyridine (MPP+) and [3H]dopamineLife Sciences, 1988
- Cigarette smoking and Parkinson's diseaseNeurology, 1986
- Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in miceEuropean Journal of Pharmacology, 1986
- Cigarette smoke impairs endothelial cell prostacyclin production.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomesBiochemical and Biophysical Research Communications, 1985
- Chemical studies on tobacco smoke. Quantitative analysis of hydrazine in tobacco and cigarette smokeAnalytical Chemistry, 1974